Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Luke Hunt

Luke Hunt

Save the Children International, UK

Title: Palliative Care in an Ebola Treatment Centre: Challenges from the Front Line

Biography

Biography: Luke Hunt

Abstract

Background
The current outbreak of Ebola Virus Disease has claimed over 11,000 lives1. Little dialogue exists on care of the dying patient in an Ebola setting. Here we consider demographic data, and discuss our experiences of delivering palliative care at a flagship Ebola Treatment Centre (ETC) in Sierra Leone.
Results
The data collection period was 8th December 2014 to 9th January 2015. Case fatality rate was 34.7% (41/118). Of those who died, the mean age was 30.3 years and 19.5 % (8/14) under 16 years. The mean time from symptom onset to death of 9.1 days (sd 4.4) with a mean time from admission onset to death of 3.7 days (sd 3.2). 2

Discussion
Patient infectivity in life and death and necessary infection control procedures delay symptom management, limit clinician time on wards and present physical barriers to non-verbal communication. Clinician inexperience and short admission time makes diagnosis of death challenging in this young cohort, while patient isolation prevents contact with relatives and restricted burial practices cause bereavement upset.

Conclusions
Introduction of preemptive medication preparation, employment of a clinical psychologist, 24 hour clinician presence, palliation decisions made by the senior physician and body bags with viewing panels appears to improve palliative care provision reducing patient distress and improving acceptance of death by relatives.

References
1. World Health Organization. WHO Ebola Situational Report- 8th July 2015. Geneva: 2015. 2. Hunt L et al, “Biochemical and Haematological Abnormalities and Risk Factors for Mortality in Patients with Ebola Virus Disease”. Pre-Publication (Accepted by Lancet Infectious Disease). 2015.